Thank you for your interest in becoming a Clarity Study Investigator

Our Study Investigators play a pivotal role in Clarity’s efforts to advance innovation in science, assist healthcare professionals in providing a higher standard of care and, ultimately, improve the quality of life for patients worldwide.

To learn more, please call today to speak to a study representative or submit the form below.

PREVENT

PAIN STUDY*

(Pain Relief: Experience and Validity: Evaluating Nano Technology)
The PREVENT study is an IRB-approved Observational Study aimed at evaluating patients’ experiences and/or perceptions and patient response for those who have received a topical Pain Patch by their clinician and those who have not. Pain management and symptoms will be evaluated by patient answers to validated pain measurement and symptom scales.
VISIT STUDY PAGE

OPTIMA-G

PAIN STUDY*

(Observing Pain Transdermal Treatments-Improving and Managing All GI Symptoms)
The OPTIMA-G study is aimed at evaluating patients’ experiences and/or perceptions for those who have been prescribed a topical/transdermal pain medication. Changes in pain and other symptoms will be evaluated.
VISIT STUDY PAGE

SELECT

PAIN STUDY and PMS Related Symptoms*

(Study Evaluating Real-Life Experience and Efficacy of CBD Treatment)
SELECT is an IRB-approved Observational Study aimed at evaluating patients’ experiences and/or perceptions and patient response for those who have been prescribed a CBD tincture or topical formulation by their clinician. Pain management, Anxiety, Sleep, Gastrointestinal, and Dermatologic symptoms will be evaluated by patient answers to validated measurement scales as well as additional survey questions regarding patient satisfaction, current medication usage, and resumption of their normal activities.
VISIT STUDY PAGE

TAPER-P

PAIN STUDY*

(Treating Athletes in Pain: Evaluating Return to Play)
The TAPER-P study evaluates perceptions and patient responses among non-elite and elite athletes who have been prescribed a topical analgesic and, if applicable, scar medication for an associated scar.
VISIT STUDY PAGE

IMPROVE

FOOT BATH TREATMENT*

(Identify and Monitor Patient Results: Observation of Various Foot Treatments and Evaluation)
IMPROVE is an IRB-approved Observational Study aimed at evaluating patients’ experiences and/or perceptions and patient response for those who have been prescribed a foot bath treatment by their clinician. Data will be evaluated based on patient and provider completed questions to validated pain measurement and symptom scales and additional survey questions regarding patient satisfaction.
VISIT STUDY PAGE

TARGET

SCAR & BURN STUDY*

(Topical Silicone in Restoring Scars and Burn Tissue: Evaluating Therapy)
The TARGET study evaluates patients’ experiences and/or perceptions of prescribed topical scar medication to treat new scars, old scars, surgical scars, burn scars, keloids, and stretch marks.
VISIT STUDY PAGE

TRIPLE-A

ALLERGY STUDY*

(Assisting and Accommodating Allergy Patients)
The TRIPLE-A study evaluates patients’ experiences and/or perceptions of premedications and preventative medications prescribed while undergoing Allergy Immunotherapy (Subcutaneous (SCIT) or Transdermal (TdIT)).
VISIT STUDY PAGE

TREAT

ALLERGY STUDY*

(Transdermal Relief: Evaluating Allergy Topicals)
The TREAT Study will evaluate patients’ experiences and or perceptions of prescribed transdermal immunotherapy (TdIT) to treat seasonal and perennial allergy symptoms.

VISIT STUDY PAGE
*All participants must meet full inclusion criteria to participate in Clarity’s studies. All medications observed in Clarity’s studies are prescribed by the Provider/Study Investigator based on medical necessity. For more information, please refer to the Study Protocols and agreements.

Become an Investigator

To Apply to Become A Study Investigator or to Join Our Network, Please Provide the Following Information:
  • Investigator Information

  • Form Verification

Areas of Research

We are currently conducting and developing clinical studies throughout the US in the following key areas:

Allergy
Chronic Sinusitis
Depression/Mental Health
Dermatology
Diabetes
GI
Immunotherapy
Mental Health
Oncology
Pain Management
Pharmacogenetics
Rheumatoid Arthritis
Scar & Burn
Sleep
Toxicology
Women’s Health
Xerostomia (Dry Mouth)

Worldwide Recognition

Our studies continue to be recognized at leading national and international meetings. Peer reviewed articles related to our study data have been published and more are in final stages of submission

BROWSE CONFERENCES & PUBLICATIONS

Current Studies

Pain management

Study

(_Pain _Relief: _Experience and _Validity: _Evaluating Nano_Technology)

PREVENT: “Pain Relief: Experience and Validity: Evaluating NanoTechonology” is an IRB-approved Observational Study aimed at evaluating patients’ experiences and/or perceptions and patient response for those who have received a topical Pain Patch by their clinician and those who have not. Pain management and symptoms will be evaluated by patient answers to validated pain measurement and symptom scales (e.g.; Brief Pain Inventory (BPI)and a Premenstrual Symptom Screening Scale, pending study participant group designation) as well as additional survey questions regarding patient satisfaction, patient quality of life, and resumption of their normal activities.

Pain management, gastrointestinal, anxiety, sleep and dermatologic issues

SELECT1 Study

(_Study _Evaluating Real-_Life _Experience and Efficacy of _CBD _Treatment)

SELECT is an IRB-approved Observational Study aimed at evaluating patients’ experiences and/or perceptions and patient response for those who have been prescribed a CBD tincture or topical formulation by their clinician. Pain management, Anxiety, Sleep, Gastrointestinal, and Dermatologic symptoms will be evaluated by patient answers to validated measurement scales (e.g.; Brief Pain Inventory (BPI), Gastrointestinal Quality of Life Index (GIQLI-10), The Pittsburgh Sleep Quality Index (PSQI), The Hospital Anxiety and Depression Scale (HADS), and the Acne Quality of Life Questionnaire (Acne-Qol)) as well as additional survey questions regarding patient satisfaction, current medication usage, and resumption of their normal activities.

Foot care

IMPROVE Study

(_Identify and _Monitor _Patient _Results: _Observation of _Various Foot Treatments and _Evaluation)

IMPROVE is an IRB-approved Observational Study aimed at evaluating patients’ experiences and/or perceptions and patient response for those who have been prescribed a foot bath treatment by their clinician. Data will be evaluated based on patient and provider completed questions to validated pain measurement and symptom scales (e.g.; QoL questionnaire) as well as additional survey questions regarding patient satisfaction and resumption of their normal activities.

If you are a physician or healthcare provider interested in becoming a Study Investigator for any of our current or future studies, we would like to hear from you. Please complete our online Study Investigator Application or call our dedicated Healthcare Provider HelpDesk at
1-800-616-9403.